【结 构 式】 |
【分子编号】20274 【品名】ethyl 2-(diethoxyphosphoryl)butanoate 【CA登记号】17145-91-4 |
【 分 子 式 】C10H21O5P 【 分 子 量 】252.247502 【元素组成】C 47.62% H 8.39% O 31.71% P 12.28% |
合成路线1
该中间体在本合成路线中的序号:(IV)A new and stereoselective synthesis of (3R-trans)-3-ethyl-1-(tert-butyldimethylsilyl)-4-[2-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one (XVII), a key intermediate in the synthesis of PS-5 has been developed: The oxidation of 3-benzyloxy-1-propanol (I) with oxalyl chloride in DMSO gives the corresponding aldehyde (II), which is condensed with the phosphonate (III) by means of NaH yielding a mixture of the (Z)- and (E)-isomers of 5-benzyloxy-2-ethyl-2-pentenoic acid ethyl ester (IV) and (V). The undesired (Z)-isomer (IV) is isomerized by treating the mixture with diphenyldisulfide in refluxing THF. The hydrolysis of (V) with LiOH in THF/methanol/water gives the expected free acid (VI), which is treated with SOCl2 in refluxing benzene to afford the acid chloride (VII). The condensation of (VII) with the chiral oxazolidinone (VIII) by means of butyllithium in THF gives the acylated compound (IX), which is treated with benzenethiol and butyllithium in THF to give the addition compound (X) that is purified by medium pressure column chromatography to eliminate the undesired diastereomer. The elimination of the oxazolidinone group of (X) by reaction with trimethylaluminum, benzylthiol and butyllithium in THF yields the thioester (XI), which is treated with silver trfluoroacetate and water to afford the corresponding free acid (XII). The reaction of (XII) with methoxyamine and 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDPC) in water affords the methoxyamide (XIII), which is methylated by means of methyl iodide and silver perchlorate to give the sulfonium salt (XIV). The cyclization of (XIV) by means of K2CO3 yields the azetidinone (XV), which is debenzylated by means of calcium in liquid ammonia affording (3R-trans)-3-ethyl-4-(2-hydrxyethyl)azetidin-2-one (XVI). Finally, this compound is silylated with tert-butyldimethylsilyl (TBDMS) trifluoromethanesulfonate affording (3R-trans)-3-ethyl-1-(tert-butyldimethylsilyl)-4-[2-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one (XVII), the desired target key intermediate in the synthesis of PS-5.
【1】 Fujiwara,Y.; Ninomiya, I.; Miyata, O.; Naito, T.; Efficient stereoselective route to beta-lactams and their application to the stereoselective synthesis of a key intermediate for carbapenem antibiotic (+)-PS-5. J Chem Soc - Perkins Trans I 1998, 14, 14, 2167. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14687 | 3-(benzyloxy)-1-propanol; 3-(Benzyloxy)propanol | 4799-68-2 | C10H14O2 | 详情 | 详情 |
(II) | 14688 | 3-(benzyloxy)propanal | C10H12O2 | 详情 | 详情 | |
(IV) | 20274 | ethyl 2-(diethoxyphosphoryl)butanoate | 17145-91-4 | C10H21O5P | 详情 | 详情 |
(V) | 20275 | ethyl (Z)-5-(benzyloxy)-2-ethyl-2-pentenoate | C16H22O3 | 详情 | 详情 | |
(VI) | 20277 | (E)-5-(benzyloxy)-2-ethyl-2-pentenoic acid | C14H18O3 | 详情 | 详情 | |
(VII) | 20278 | (E)-5-(benzyloxy)-2-ethyl-2-pentenoyl chloride | C14H17ClO2 | 详情 | 详情 | |
(VIII) | 12867 | (4S)-4-Isopropyl-1,3-oxazolidin-2-one; (R)-4-Isopropyl-2-oxazolidinone | 17016-83-0 | C6H11NO2 | 详情 | 详情 |
(IX) | 20280 | (4S)-3-[(E)-5-(benzyloxy)-2-ethyl-2-pentenoyl]-4-isopropyl-1,3-oxazolidin-2-one | C20H27NO4 | 详情 | 详情 | |
(X) | 20281 | (4S)-3-[(2S,3S)-5-(benzyloxy)-2-ethyl-3-(phenylsulfanyl)pentanoyl]-4-isopropyl-1,3-oxazolidin-2-one | C26H33NO4S | 详情 | 详情 | |
(XI) | 20282 | S-benzyl (2R,3S)-5-(benzyloxy)-2-ethyl-3-(phenylsulfanyl)pentanethioate | C27H30O2S2 | 详情 | 详情 | |
(XII) | 20283 | (2S,3S)-5-(benzyloxy)-2-ethyl-3-(phenylsulfanyl)pentanoic acid | C20H24O3S | 详情 | 详情 | |
(XIII) | 20284 | (2S,3S)-5-(benzyloxy)-2-ethyl-N-methoxy-3-(phenylsulfanyl)pentanamide | C21H27NO3S | 详情 | 详情 | |
(XIV) | 20285 | [(1S,2S)-1-[2-(benzyloxy)ethyl]-2-[(methoxyamino)carbonyl]butyl](methyl)phenylsulfonium iodide | C22H30INO3S | 详情 | 详情 | |
(XV) | 20286 | (3R,4R)-4-[2-(benzyloxy)ethyl]-3-ethyl-1-methoxy-2-azetidinone | C15H21NO3 | 详情 | 详情 | |
(XVI) | 20287 | (3R,4R)-3-ethyl-4-(2-hydroxyethyl)-2-azetidinone | C7H13NO2 | 详情 | 详情 | |
(XVII) | 20051 | (3R,4R)-1-[tert-butyl(dimethyl)silyl]-4-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-3-ethyl-2-azetidinone | C19H41NO2Si2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)Mitsunobu coupling of geranylgeraniol (I) with N-hydroxyphthalimide (II) in the presence of diethyl azodicarboxylate and triphenylphosphine produced the N-alkoxyphthalimide (III). Subsequent hydrazinolysis of the phthaloyl group of (III) gave rise to the O-alkyl hydroxylamine (IV). (2-Diethylphosphono)butyric acid (VI), prepared by partial hydrolysis of triethyl ester (V), was then coupled with hydroxylamine (IV) using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide-HCl and 1-hydroxybenzotriazole to furnish the N-alkoxyamide (VII). The phosphonate ester groups were finally cleaved by treatment with bromotrimethylsilane and 2,4,6-collidine.
【1】 Balsamo, A.; Macchia, B.; Macchia, M.; Baldacci, M.; Danesi, R.; Del Tacca, M. (Laboratori Baldacci SpA); Novel geranylgeranyl-derivs., process for the preparation thereof and related pharmaceutical compsns.. EP 0862575; JP 2000500758; WO 9719091 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 34476 | (2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraen-1-ol | C20H34O | 详情 | 详情 | |
(II) | 13505 | N-Hydroxyphthalimide; 2-Hydroxy-1H-isoindole-1,3(2H)-dione | 524-38-9 | C8H5NO3 | 详情 | 详情 |
(III) | 34477 | 2-[[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl]oxy]-1H-isoindole-1,3(2H)-dione | C28H37NO3 | 详情 | 详情 | |
(IV) | 34478 | O-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl]hydroxylamine; (2E,6E,10E)-1-(aminooxy)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraene | C20H35NO | 详情 | 详情 | |
(V) | 20274 | ethyl 2-(diethoxyphosphoryl)butanoate | 17145-91-4 | C10H21O5P | 详情 | 详情 |
(VI) | 34479 | 2-(diethoxyphosphoryl)butyric acid | C8H17O5P | 详情 | 详情 | |
(VII) | 34480 | diethyl 1-[([[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl]oxy]amino)carbonyl]propylphosphonate | C28H50NO5P | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(III)5-Formyl-2-methoxybenzoic acid (I) is converted to the corresponding benzyl ester (II) upon treatment with benzyl bromide and potassium bicarbonate. Subsequent Wadsworth-Emmons condensation between aldehyde (II) and triethyl 2-phosphonobutyrate (III) gives the unsaturated ester (IV). Double bond hydrogenation in (IV) with concomitant hydrogenolysis of the benzyl ester affords acid (V), which is subsequently coupled with 4-(trifluoromethyl)benzyl amine (VI), via the mixed anhydride with ethyl chloroformate, to produce amide (VII). The ethyl ester group of (VII) is finally hydrolyzed to the title carboxylic acid employing NaOH in aqueous ethanol.
【1】 Tanase, T.; Nomura, M.; Miyachi, H.; et al.; Design, synthesis and evaluation of substituted phenylpropanoic acid derivatives as peroxisome proliferator-activated receptor (PPAR) activators: Novel human PPARalpha-selective activators. Bioorg Med Chem Lett 2002, 12, 1, 77. |
【2】 Murakami, K.; Takahashi, Y.; Nomura, M.; Miyachi, H.; Ide, T.; Tsunoda, M.; Tanase, T. (Kyorin Pharmaceutical Co., Ltd.); Substd. phenylpropionic acid derivs. as agonists to human peroxisome proliferator-activated receptor (PPAR) alpha. EP 1184366; JP 2001055367; WO 0075103 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 57501 | 5-formyl-2-methoxybenzoic acid | C9H8O4 | 详情 | 详情 | |
(II) | 57502 | benzyl 5-formyl-2-methoxybenzoate | C16H14O4 | 详情 | 详情 | |
(III) | 20274 | ethyl 2-(diethoxyphosphoryl)butanoate | 17145-91-4 | C10H21O5P | 详情 | 详情 |
(IV) | 57503 | benzyl 5-[(E)-2-(ethoxycarbonyl)-1-butenyl]-2-methoxybenzoate | C22H24O5 | 详情 | 详情 | |
(V) | 57504 | 5-[2-(ethoxycarbonyl)butyl]-2-methoxybenzoic acid | C15H20O5 | 详情 | 详情 | |
(VI) | 21925 | [4-(trifluoromethyl)phenyl]methanamine; 4-(trifluoromethyl)benzylamine | 3300-51-4 | C8H8F3N | 详情 | 详情 |
(VII) | 57505 | ethyl 2-[4-methoxy-3-({[4-(trifluoromethyl)benzyl]amino}carbonyl)benzyl]butanoate | C23H26F3NO4 | 详情 | 详情 |